Tryptophan depletion predicts lower positive affect in sexual minority men living with HIV who use methamphetamine

Ji Young Lee, Tiffany R. Glynn, Judith T. Moskowitz, Dietmar Fuchs, Torsten B. Neilands, Samantha E. Dilworth, Daniel J. Feaster, Allan Rodriguez, Adam W. Carrico

Research output: Contribution to journalArticlepeer-review

Abstract

This longitudinal study with 76 sexual minority men living with HIV who use methamphetamine examined whether dysregulation of essential amino acid precursors for neurotransmitters at baseline predicted positive and negative affect at 15 months. After controlling for covariates including baseline positive affect, a higher baseline kynurenine/tryptophan (K/T) ratio independently predicted lower positive affect at 15 months (β = − 18.31; 95% CI = − 35.35, − 1.27; p = 0.036). Future clinical research should examine whether bio-behavioral interventions targeting tryptophan degradation could optimize treatments for people living with co-occurring HIV and stimulant use disorders.

Original languageEnglish (US)
Pages (from-to)178-182
Number of pages5
JournalJournal of neurovirology
Volume27
Issue number1
DOIs
StatePublished - Feb 2021

Keywords

  • HIV
  • Immune activation
  • Methamphetamine
  • Positive affect
  • Tryptophan

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience
  • Virology

Fingerprint

Dive into the research topics of 'Tryptophan depletion predicts lower positive affect in sexual minority men living with HIV who use methamphetamine'. Together they form a unique fingerprint.

Cite this